If we can shut down the funding that Russia is getting, then we can put pressure on Vladimir Putin to come to the table.
As President Zelenskyy said in Washington: "Ukraine needs this bill."
Congress Member Profile|U.S. Senator|Democrat|New Hampshire
Jeanne Shaheen
SoupScoreanalysis-first civic rating · view full breakdown
Loading…
Voting Record — 885
Yes42%
No54%
Present0%
Not Voting4%
Party align86%
Cross-party14%
SoupScore
District Map
Senate District (Statewide)
U.S. Census Bureau boundary data.
Social & Web
External Resources
Jeanne Shaheen
U.S. SenatorDemocratNew Hampshire
SoupScore
Jeanne's ATmosphere Activity
20 recent posts · 96 sponsored · 325 cosponsored
Recent ATmosphere posts, sponsorships, and cosponsorships.
Today marks the 61st anniversary of Medicare and Medicaid, landmark programs that expanded health care access to millions.
Unfortunately, Republicans are intent on reversing this progress—slashing health care funding to ensure less, not more, can access the care they need.
There is no strategy to end the war in Iran.
We are now in a stalemate that is endangering our service members and forcing the American taxpayer to pay the price.
Our Russia and Iran sanctions legislation is narrowly crafted to address the top five users of Russian oil and gas and to protect our allies who are making important efforts to get off Russian gas.
We must cut off the revenues that are funding Russia's war machine.
As health care prices soar, too many Americans cannot afford the medicine they need to live.
To protect the over 8 million Americans who depend on insulin to survive, we must pass my INSULIN Act and cap this life-saving medicine at $35 per month.
The DoD's lack of transparency on the war in Iran is a disservice to the American people and most importantly to the families of our service members.
The Pentagon must immediately provide a complete accounting of those who have been killed, injured or wounded in this operation.
As energy prices soar due to the war in Iran, we should do all we can to insulate the American people from these costs.
Yet the Administration is doing just the opposite—rolling back energy-efficiency and exposing Americans to even higher energy bills.
www.nytimes.com/2026/07/21/c...
With too many feeling squeezed by rising health care prices, capping insulin prices at $35 a month is a step we can take right now to deliver real financial relief.
My INSULIN act would do just that. I was proud to see it advance out of the HELP Committee last week. Now let’s make it law!
Before the President's war in Iran, Americans were already struggling to afford everyday essentials like groceries. It’s only gotten worse since.
The President said he was going to lower costs. Instead, he’s making life harder for American families at every turn.
I was proud to help represent New Hampshire's aerospace sector on the global stage at the Farnborough Air Show last weekend.
As our top export sector, it was great to connect Granite State businesses with industry leaders to fuel innovation and economic growth in our state!
As health care prices soar, millions of Americans are forced to choose between affording life-saving insulin or paying for rent or groceries.
No one should have to make that choice. By capping insulin at $35 per month, my INSULIN Act ensures that’s the case.
The Iran War never should have started, and the President hasn't achieved any of the goals he set out.
We have a more hardline regime, we haven't dealt with their nuclear program and now the Strait is a pawn in this war—raising costs on American families.
This war needs to end.
I thank Senators Collins, Warnock and Kennedy for their leadership on our INSULIN Act to cap insulin at $35 a month for Americans across the country. We are proud that critical legislation advanced out of the Senate HELP Committee today.
Our full statement:
Doug Mastriano has stated that the European Union is a "rising rival" to the U.S. comparable to China.
He's now being nominated as ambassador to Slovakia—an EU nation.
I asked Secretary Hegseth: “At what point do you stop asking the American people to foot the bill for a war they don’t support?”
He had no response.
Nearly half of those managing diabetes are forced to shell out thousands a year to afford the insulin they need to live.
This cannot stand.
We must cap insulin at $35 a month to ensure everyone can afford the life-saving medication they need.
In just the past few weeks we’ve seen two deadly shootings involving ICE, continuing a disturbing, dangerous trend of recklessness by the agency.
In response, I joined my Senate colleagues in calling on DHS to implement measures to help prevent future deadly encounters.
SoupScore Breakdown
Loading analysis metrics…
Voting History885 total votesExpandCollapse
Voting History
885 total votes
Recent roll calls with party-majority context so it is easier to scan how this member tends to vote.
| Date | Bill | Question | Position | Party Maj | Align? | Result |
|---|---|---|---|---|---|---|
| 2025-09-30 | H.R. 5371 (119th) | Final passage | NO | NO | ✓ | Bill Defeated (55-45, 3/5 majority required) |
| 2025-09-30 | S. 2882 (119th) | Final passage | YES | YES | ✓ | Bill Defeated (47-53, 3/5 majority required) |
| 2025-09-29 | S. 2806 (119th) | End filibuster to begin debate | NO | NO | ✓ | Cloture on the Motion to Proceed Rejected (37-61, 3/5 majority required) |
| 2025-09-29 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (54-45) |
| 2025-09-29 | — | End debate | YES | NO | ✕↔ | Cloture Motion Agreed to (54-45) |
| 2025-09-19 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (47-43) |
| 2025-09-19 | — | End debate | YES | NO | ✕↔ | Cloture Motion Agreed to (47-45) |
| 2025-09-19 | H.R. 5371 (119th) | Final passage | NO | NO | ✓ | Bill Defeated (44-48, 3/5 majority required) |
| 2025-09-19 | S. 2882 (119th) | Final passage | YES | YES | ✓ | Bill Defeated (47-45, 3/5 majority required) |
| 2025-09-18 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (51-47) |
| 2025-09-17 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (52-47) |
| 2025-09-17 | — | Decision of the Chair PN12-19 and PN25-28 and PN12-45 and PN22-1 and PN22-2 and PN22-5 and PN22-27 and PN22-20 and PN22-21 and PN26-8 and PN26-34 and PN26-35 and PN55-41 and PN22-4 and PN22-8 and PN22-19 and PN26-1 and PN22-23 and PN25-40 and PN26-7 and PN26-19 and PN26-31 and PN60-3 and PN26-44 and PN25-2 and PN55-16 and PN60-9 and PN60-10 and PN129-8 and PN26-45 and PN141-37 and PN141-7 and PN141-28 and PN12-22 and PN25-21 and PN22-3 and PN26-22 and PN13-5 and PN22-24 and PN25-33 and PN141-18 and PN150-5 and PN345-16 and PN55-42 and PN54-6 and PN54-7 and PN55-45 and PN55-25 | YES | YES | ✓ | Decision of Chair Not Sustained (47-52) |
| 2025-09-17 | — | Motion to Reconsider PN55-25 and PN55-45 and PN54-7 and PN54-6 and PN55-42 and PN345-16 and PN150-5 and PN141-18 and PN25-33 and PN22-24 and PN13-5 and PN26-22 and PN22-3 and PN25-21 and PN12-22 and PN141-28 and PN141-7 and PN141-37 and PN26-45 and PN129-8 and PN60-10 and PN60-9 and PN55-16 and PN25-2 and PN26-44 and PN60-3 and PN26-31 and PN26-19 and PN26-7 and PN25-40 and PN22-23 and PN26-1 and PN22-19 and PN22-8 and PN22-4 and PN55-41 and PN26-35 and PN26-34 and PN26-8 and PN22-21 and PN22-20 and PN22-27 and PN22-5 and PN22-2 and PN22-1 and PN12-45 and PN12-19 and PN25-28 | NO | NO | ✓ | Motion to Reconsider Agreed to (51-47) |
| 2025-09-17 | — | End debate | NO | NO | ✓ | Cloture Motion Rejected (51-48, 3/5 majority required) |
| 2025-09-16 | S. Con. Res. 22 (119th) | Begin consideration | NO | NO | ✓ | Motion to Proceed Rejected (36-62) |
| 2025-09-16 | S.J. Res. 60 (119th) | Begin consideration | YES | YES | ✓ | Motion to Proceed Rejected (47-51) |
| 2025-09-15 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (48-47) |
| 2025-09-15 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (50-44) |
| 2025-09-15 | S. Res. 377 (119th) | Approve resolution | NO | NO | ✓ | Resolution Agreed to (51-44) |
| 2025-09-11 | S. Res. 377 (119th) | End debate | NO | NO | ✓ | Cloture Motion Agreed to (53-43) |
| 2025-09-11 | S. Res. 377 (119th) | Decision of the Chair S.Res. 377 | YES | YES | ✓ | Decision of Chair Not Sustained (45-53) |
| 2025-09-11 | S. Res. 377 (119th) | Motion to Reconsider S.Res. 377 | NO | NO | ✓ | Motion to Reconsider Agreed to (52-45) |
| 2025-09-11 | S. Res. 377 (119th) | End debate | NO | NO | ✓ | Cloture Motion Rejected (52-47, 3/5 majority required) |
| 2025-09-10 | S. 2296 (119th) | Kill the motion | NO | NO | ✓ | Motion to Table Agreed to (51-49) |
| 2025-09-09 | S. Res. 377 (119th) | Begin consideration | NO | NO | ✓ | Motion to Proceed Agreed to (53-45) |
| 2025-09-09 | S. Res. 377 (119th) | Kill the motion | NO | NO | ✓ | Motion to Table Agreed to (53-46) |
| 2025-09-09 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (53-45) |
| 2025-09-09 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (53-44) |
| 2025-09-09 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (49-46) |
| 2025-09-09 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (51-46) |
| 2025-09-09 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (52-45) |
| 2025-09-08 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-43) |
| 2025-09-04 | S. 2296 (119th) | Begin consideration | YES | YES | ✓ | Motion to Proceed Agreed to (83-13) |
| 2025-09-04 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (53-46) |
| 2025-09-04 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (53-45) |
| 2025-09-02 | S. 2296 (119th) | End filibuster to begin debate | YES | YES | ✓ | Cloture on the Motion to Proceed Agreed to (84-14, 3/5 majority required) |
| 2025-08-02 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (71-23) |
| 2025-08-02 | — | Confirm nominee | YES | — | — | Nomination Confirmed (72-22) |
| 2025-08-02 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (59-35) |
| 2025-08-02 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (52-42) |
| 2025-08-02 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-45) |
| 2025-08-02 | — | Confirm nominee | YES | YES | ✓ | Nomination Confirmed (78-17) |
| 2025-08-02 | — | End debate | YES | YES | ✓ | Cloture Motion Agreed to (76-19) |
| 2025-08-02 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (50-45) |
| 2025-08-02 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (51-45) |
| 2025-08-02 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (52-44) |
| 2025-08-02 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (49-45) |
| 2025-08-02 | — | Confirm nominee | NO | NO | ✓ | Nomination Confirmed (49-44) |
| 2025-08-02 | — | End debate | NO | NO | ✓ | Cloture Motion Agreed to (51-45) |
| 2025-08-02 | — | Confirm nominee | YES | NO | ✕↔ | Nomination Confirmed (53-44) |
Alignment stats consider only votes where a clear yes/no majority existed for the legislator's party. Cross-party marks divergence where the vote matched the opposite party majority. ↔ indicates cross-party divergence.